ANGAMO BIOSCIENCES, INC.
Common Stock
PLACEMENT AGENCY AGREEMENT
November 10, 2005
JMP SECURITIES LLC
600 Montgomery Street
Suite 1100
San Francisco, California 94111
PIPER JAFFRAY & CO.
U.S. Bancorp Center
800 Nicollet Mall
Minneapolis, Minnesota 55402
LEERINK SWANN & COMPANY
One Federal Street
37th Floor
Boston, Massachusetts 02110
Ladies and Gentlemen:
Sangamo BioSciences, Inc., a Delaware corporation (the “Company”), proposes, subject to the t
Sangamo BioSciences, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms
and conditions contained herein to issue and sell to certain investors (each an “Investor” and, collectively, the
“Investors”), an aggregate of up to 5,080,000 shares of common stock, $0.01 par value per share (the
“Common Stock”), of the Company directly to the Investors. The aggregate of 5,080,000 shares of Common
Stock so proposed to be sold is hereinafter referred to as the “Shares.
” The Company desires to engage JMP
Securities LLC and Piper Jaﬀray & Co. as its joint lead placement agents (the “Joint Lead Placement
Agents”) and Leerink Swann & Company as its co-placement agent (the “Co-Placement Agent” and,
collectively with the Joint Lead Placement Agents, the “Placement Agents”) in connection with such issuance
and sale. The Shares are more fully described in the Registration Statement (as hereinafter defined).Payment of the purchase price for, and delivery of, the Shares shall be made at a closing
(the “Closing”) at the oﬃces of Morgan, Lewis & Bockius LLP, counsel for the Company, located at One Market
Street, San Francisco, California at 7:00 a.m., local time